Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

FORLANO, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.245
AS - Asia 1.100
SA - Sud America 727
EU - Europa 252
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 75
Totale 3.502
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.120
BR - Brasile 562
SG - Singapore 332
VN - Vietnam 325
CN - Cina 276
DE - Germania 116
AR - Argentina 74
MA - Marocco 69
IT - Italia 51
HK - Hong Kong 47
EC - Ecuador 38
ID - Indonesia 37
CA - Canada 36
MX - Messico 31
FR - Francia 28
BD - Bangladesh 20
PK - Pakistan 19
ZA - Sudafrica 17
CO - Colombia 16
IN - India 15
GB - Regno Unito 14
PY - Paraguay 14
RU - Federazione Russa 14
HN - Honduras 11
TT - Trinidad e Tobago 10
NI - Nicaragua 9
CL - Cile 7
CR - Costa Rica 7
CW - ???statistics.table.value.countryCode.CW??? 6
EG - Egitto 6
VE - Venezuela 6
AT - Austria 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
IQ - Iraq 5
NL - Olanda 5
UY - Uruguay 5
DZ - Algeria 4
FI - Finlandia 4
GP - Guadalupe 4
PE - Perù 4
NP - Nepal 3
SE - Svezia 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
ES - Italia 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
PL - Polonia 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TR - Turchia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
MU - Mauritius 1
MY - Malesia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
Totale 3.433
Salva come PNG Salva come JPEG
Città #
Dallas 515
Singapore 156
Ho Chi Minh City 128
Frankfurt am Main 96
San Jose 87
Ashburn 83
Hefei 65
Casablanca 63
The Dalles 58
Hanoi 53
Beijing 50
San Francisco 50
Hong Kong 43
São Paulo 36
Los Angeles 34
New York 25
Mexico City 18
Guayaquil 16
Rio de Janeiro 16
Curitiba 15
Haiphong 15
Islamabad 15
Chardon 12
Da Nang 12
Brasília 11
Thái Bình 11
Quito 10
Bắc Giang 9
Chicago 9
Council Bluffs 9
Johannesburg 9
Managua 9
Munich 9
Porto Alegre 9
Asunción 8
Biên Hòa 8
Düsseldorf 8
Jakarta 8
Santa Clara 8
Buenos Aires 7
Montreal 7
Phoenix 7
Belo Horizonte 6
Campinas 6
Guarulhos 6
Hillsboro 6
Hải Dương 6
Ribeirão Preto 6
Atlanta 5
Cao Lanh 5
Fortaleza 5
Lauterbourg 5
Milan 5
Ninh Bình 5
Orem 5
Princeton 5
Rome 5
San José 5
Sorocaba 5
Sumaré 5
São José dos Campos 5
Thái Nguyên 5
Toronto 5
Belford Roxo 4
Brooklyn 4
Canoas 4
Caxias do Sul 4
Chaguanas 4
Chennai 4
Columbus 4
Corrientes 4
Cotia 4
Formosa 4
Guatemala City 4
Huế 4
Maceió 4
Monterrey 4
Montes Claros 4
New Delhi 4
Newark 4
North Bergen 4
Ourinhos 4
Oxnard 4
Paulista 4
Recife 4
San Pedro Sula 4
Santo André 4
St Petersburg 4
São Gonçalo 4
Taboão da Serra 4
Turin 4
Turku 4
Willemstad 4
Algiers 3
Bogotá 3
Boston 3
Buffalo 3
Bắc Ninh 3
Can Tho 3
Cape Town 3
Totale 2.069
Salva come PNG Salva come JPEG
Nome #
Spatial lipidomics reveals sphingolipid metabolism as anti-fibrotic target in the liver 221
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII 168
Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus 81
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 70
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 69
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective 67
A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies 64
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease 63
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease 63
Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study 62
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 62
Automated quantitation of histological features could predict mortality in patients with severe alcoholic hepatitis 62
Current and future pharmacological therapies for managing cirrhosis and its complications 60
Automated quantitation of steatosis, inflammation, ballooning and fibrosis using machine learning in routine histological images of liver biopsies of patients with NAFLD 59
Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease 59
Current and future pharmacological therapies for managing cirrhosis and its complications 58
Binge Eating Disorder is associated with an unfavourable body mass composition in patients with Non-Alcoholic fatty liver disease 58
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 57
Deep Learning in Liver Biopsies using Convolutional Neural Networks 56
Another arrow in the NASH quiver? 55
A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients 54
Quantification of Liver Fibrosis-A Comparative Study 54
NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials 54
Fibrosis severity scoring on Sirius red histology with multiple-instance deep learning 52
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 52
Detection of senescence using machine learning algorithms based on nuclear features 51
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 50
Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts 50
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 48
A prospective cohort study for the prevalence and screening policy of NAFLD in patients with T2DM in primary care 47
Liver function tests in NAFLD: Changes in upper normal limits, does it really matter? 47
Non-alcoholic fatty liver disease and cardiovascular risk: an update 47
Fat Droplets Identification in Liver Biopsies using Supervised Learning Techniques 47
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 47
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply 47
IN-HOSPITAL MORTALITY IS ASSOCIATED WITH INFLAMMATORY RESPONSE IN NAFLD PATIENTS ADMITTED FOR COVID-19 46
THE ROLE OF SUB-MUCOSAL COLLAGEN DEPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 45
Training of Deep Convolutional Neural Networks to Identify Critical Liver Alterations in Histopathology Image Samples 45
The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease 44
Liver function tests in NAFLD: Changes in upper normal limits, does it really matter? 44
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie SocietA Italiana di Medicina Interna) Study 44
IMPACT OF BMI AND ETHNICITY ON HISTOLOGY AS ASSESSED BY AUTOMATED QUANTITATION IN LIVER BIOPSIES OF PATIENTS WITH NAFLD 44
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply 43
SUB-MUCOSAL COLLAGEN DEPOSITION IS ASSOCIATED WITH INFLAMMATION MARKERS AND DISEASE ACTIVITY INDICES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: AN ONGOING STUDY 43
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? 43
Evaluating the impact of non-selective beta-blocker use in decompensated cirrhosis based on setting of patient care 42
Automated Quantitation of Steatosis, Fibrosis and Ballooning Using Machine Learning in Routine Histological Images of Liver Biopsies of Patients with NAFLD 42
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19 41
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 40
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease: The importance of an elevated mean platelet volume 40
Ensemble Convolutional Neural Network Classification for Pancreatic Steatosis Assessment in Biopsy Images 40
Screening for NAFLD-Current Knowledge and Challenges 39
Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review 39
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume 38
Non-alcoholic fatty liver disease and cardiovascular risk: an update 36
Non-Alcoholic Fatty Liver Disease and Vascular Disease 36
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease 36
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply 36
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply 36
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 36
Letter: liver disease and COVID-19-not the perfect storm 36
Multi-tissue pro fi ling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue in fl ammation and liver steatosis in obesity 36
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 36
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 34
Transfer Learning versus Custom CNN Architectures in NAFLD Biopsy Images 31
Metabolic-associated steatotic liver disease (MASLD): how I evolved my approach to diagnosis and staging 15
Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 15
Deep learning layer-specific collagen quantification correlates with activity and is associated with outcomes in Crohn’s disease 11
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B 9
Totale 3.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025282 0 0 0 0 0 0 0 0 160 34 76 12
2025/20262.775 73 345 682 900 155 42 125 113 77 195 51 17
2026/2027445 12 35 117 281 0 0 0 0 0 0 0 0
Totale 3.502